Centenial Surgical Suture Ltd
BSE:531380
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (3.5), the stock would be worth ₹84.5 (15% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 4.1 | ₹99.25 |
0%
|
| 3-Year Average | 3.5 | ₹84.5 |
-15%
|
| 5-Year Average | 3.5 | ₹84.5 |
-15%
|
| Industry Average | 36.2 | ₹870.24 |
+777%
|
| Country Average | 23 | ₹552.19 |
+456%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
C
|
Centenial Surgical Suture Ltd
BSE:531380
|
362.1m INR | 4.1 | -33.3 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY | 39.4 | 39.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.1B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29B CHF | 16 | 37.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
91B DKK | 13.5 | 23.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD | 21.3 | 30.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.2B GBP | 12 | 32.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
905.8B JPY | 22.4 | 51.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 19.6 | -15.4 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.3T KRW | -90 | -37.8 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.5B CNY | 22.2 | 22 |
Market Distribution
| Min | 0.5 |
| 30th Percentile | 14 |
| Median | 23 |
| 70th Percentile | 39.7 |
| Max | 28 676 |
Other Multiples
Centenial Surgical Suture Ltd
Glance View
Centenial Surgical Suture Ltd. is a medical device company, which engages in the manufacturing of surgical sutures and medical devices. The company is headquartered in Thane, Maharashtra. The company went IPO on 2005-09-16. The firm operates through the Medical Devices segment. The firm's products include atraumatic needles and sutures (absorbable and non-absorbable) and cardio blades. Its absorbable sutures consist of natural sutures and synthetic sutures, where natural sutures include Centenial-Catgut Plain, and Centenial-Catgut Chromic, and synthetic sutures include Centicryl Braided, Centicryl Rapid, Monosynth and Centisorb. Its non-absorbable sutures include Centilene, Centlon, Centsilk, Centibond, Centsteel and Centipace. Its medical devices include T-SUIT, Centilene Mesh, Skin Stapler, Centiclip, Aortic Punch and Kinfe. The company supplies technical specifications, including tables of dimensions and strength values, as well as chemicals and dye stuffs used in manufacturing each suture material.
